Answers are grounded in this paper and cite their sources.
Characterizes genetic mutations in neonatal seizures, indicating the importance of early diagnosis.
Background: Early-stage seizures caused by an undetermined etiology cannot be treated with effective antiepileptic drugs in a timely manner, leading to poor seizure control and severely affecting long-term prognosis. Therefore, early clarification of the cause and targeted timely treatment are crucial. Objective: To characterize the clinical features and genetic mutations in neonatal seizures, particularly those of unknown cause. Methods: Clinical data from 56 neonates with seizures were retrospectively analyzed. Family-based whole-exome sequencing was performed in six cases of undetermined etiology. The KCNQ2 variant was classified according to the ACMG guidelines. Basic statistical comparisons were performed using the chi-square test. Results: Hypoxic-ischemic encephalopathy (HIE) was the most common cause (23.21%, 13/56), with most seizures occurring within the first three days of life. Subtle seizures were the predominant type (46.42%, 26/56). Abnormal amplitude-integrated EEG findings were observed in 58.82% (30/51). The HIE group had a significantly higher proportion of seizures occurring within the first three days of life compared to the non-HIE group (p = 0.01). A novel heterozygous KCNQ2 mutation (c.766G>T, p.Gly256Trp) was identified and classified as likely pathogenic according to the ACMG guidelines. Conclusions: HIE remains a leading cause of early-onset neonatal seizures. A novel likely pathogenic KCNQ2 mutation expands the genetic spectrum of neonatal seizures, highlighting the value of genetic testing.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: